FELDENE

This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Cyprus, Ecuador, Estonia, France, Hong Kong SAR China, Ireland, Israel, Italy, Japan, Mexico, Poland, South Africa, Spain, Tunisia, UK.

Active ingredients

The drug FELDENE contains one active pharmaceutical ingredient (API):

1
UNII 13T4O6VMAM - PIROXICAM
 

Piroxicam is a non-steroidal anti-inflammatory agent with analgesic and antipyretic activity. It is effective regardless of the aetiology of the inflammation.

 
Read more about Piroxicam

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 FELDENE Capsule, FELDENE D Tablet MPI, EU: SmPC Pharmaceutical Benefits Scheme (AU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
M01AC01 Piroxicam M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AC Oxicams
Discover more medicines within M01AC01
M02AA07 Piroxicam M Musculo-skeletal system → M02 Topical products for joint and muscular pain → M02A Topical products for joint and muscular pain → M02AA Antiinflammatory preparations, non-steroids for topical use
Discover more medicines within M02AA07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
AU Pharmaceutical Benefits Scheme 1896T, 1897W, 1898X, 5202T, 5203W, 5204X
BR Câmara de Regulação do Mercado de Medicamentos 522717120067017, 522717120067117, 522717120067217, 522717120067317, 522717120067417, 522717120067517, 522717120067617, 522717120067717, 522717120067817, 522718100081803
EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria 30185-04-12, 3037-MEE-0917
EE Ravimiamet 1018516
ES Centro de información online de medicamentos de la AEMPS 55382, 55806, 58085, 60070
FR Base de données publique des médicaments 65182102, 65898475, 67214342, 67633600
GB Medicines & Healthcare Products Regulatory Agency 138762, 142326, 161757, 181683, 181687, 182568, 24557, 24559, 381333
HK Department of Health Drug Office 46650
IE Health Products Regulatory Authority 24066
IL מִשְׂרַד הַבְּרִיאוּת 2669
IT Agenzia del Farmaco 024249029, 024249068
JP 医薬品医療機器総合機構 2649730M1077
MX Comisión Federal para la Protección contra Riesgos Sanitarios 047M86, 068M87, 188M80, 439M86
PL Rejestru Produktów Leczniczych 100023759, 100264530, 100290443, 100340402, 100434830, 100451782
TN Direction de la Pharmacie et du Médicament 9243011, 9243012, 9243013, 9243015, 9243016
US FDA, National Drug Code 0069-3220, 0069-3230
ZA Health Products Regulatory Authority M/3.1/0007

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.